References
1. Aristizabal P, Winestone LE, Umaretiya P, Bona K. Disparities in
Pediatric Oncology: The 21st Century Opportunity to Improve Outcomes for
Children and Adolescents With Cancer. Am Soc Clin Oncol Educ
Book. 2021;41:e315-e326.
2. Bona K, Li Y, Winestone L, et al. Poverty and Targeted Immunotherapy:
Survival in Children’s Oncology Group Clinical Trials for High-Risk
Neuroblastoma. J Natl Cancer Inst. 2021;113(3):282-291.
3. Singh GK, Jemal A. Socioeconomic and Racial/Ethnic Disparities in
Cancer Mortality, Incidence, and Survival in the United States,
1950-2014: Over Six Decades of Changing Patterns and Widening
Inequalities. J Environ Public Health. 2017;2017:2819372.
4. Wolfson JA, Bhatia S, Ginsberg J, et al. Expenditures among young
adults with acute lymphoblastic leukemia by site of care. Cancer.2021;127(11):1901-1911.
5. Aristizabal P, Singer J, Cooper R, et al. Participation in pediatric
oncology research protocols: Racial/ethnic, language and age-based
disparities. Pediatr Blood Cancer. 2015;62(8):1337-1344.
6. Kahn JM, Kelly KM, Pei Q, et al. Survival by Race and Ethnicity in
Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children’s
Oncology Group Study. J Clin Oncol. 2019;37(32):3009-3017.
7. Winestone LE, Getz KD, Miller TP, et al. The role of acuity of
illness at presentation in early mortality in black children with acute
myeloid leukemia. Am J Hematol. 2017;92(2):141-148.
8. Gupta S, Teachey DT, Devidas M, et al. Racial, Ethnic, and
Socioeconomic Factors Result in Disparities in Outcome Among Children
with Acute Lymphoblastic Leukemia Not Fully Attenuated By Disease
Prognosticators: A Children’s Oncology Group (COG) Study. Oral abstract
presented at American Society of Hematology; 2021.
9. Fleisch Marcus A, Illescas AH, Hohl BC, Llanos AAM. Relationships
between social isolation, neighborhood poverty, and cancer mortality in
a population-based study of US adults. PLOS ONE.2017;12(3):e0173370.
10. Loree JM, Anand S, Dasari A, et al. Disparity of Race Reporting and
Representation in Clinical Trials Leading to Cancer Drug Approvals From
2008 to 2018. JAMA Oncol. 2019;5(10):e191870-e191870.
11. Kahn JM, Gray II DM, Oliveri JM, Washington CM, DeGraffinreid CR,
Paskett ED. Strategies to improve diversity, equity, and inclusion in
clinical trials. Cancer. 2022;128(2):216-221.
12. Zheng DJ, Shyr D, Ma C, Muriel AC, Wolfe J, Bona K. Feasibility of
systematic poverty screening in a pediatric oncology referral center.Pediatr Blood Cancer. 2018:e27380.
13. Bona K, London WB, Guo D, Frank DA, Wolfe J. Trajectory of Material
Hardship and Income Poverty in Families of Children Undergoing
Chemotherapy: A Prospective Cohort Study. Pediatr Blood Cancer.2016;63(1):105-111.
14. Children’s Defense Fund (CDF). The State of America’s Children.
2021;
https://www.childrensdefense.org/state-of-americas-children/.
15. Ilowite MF, Al-Sayegh H, Ma C, et al. The relationship between
household income and patient-reported symptom distress and quality of
life in children with advanced cancer: A report from the PediQUEST
study. Cancer. 2018;124(19):3934-3941.
16. Umaretiya PJ, Koch VB, Stevenson KE, et al. Household material
hardship and parental distress in a multicenter clinical trial for
pediatric acute lymphoblastic leukemia. J Clin Oncol.2021;39(15_suppl):10025-10025.
17. Muffly L, Tardif C, de Souza J. Financial toxicity in children,
adolescent, and young adult cancer patients and their families: A large
national registry analysis from the family reach foundation. J
Clin Oncol. 2016;34(15_suppl):6615-6615.
18. Roser K, Erdmann F, Michel G, Winther JF, Mader L. The impact of
childhood cancer on parents’ socio-economic situation—A systematic
review. Psycho-Oncology. 2019;28(6):1207-1226.
19. Umaretiya PJ, Revette A, Seo A, et al. PediCARE: Development of a
poverty-targeted intervention for pediatric cancer. Pediatr Blood
Cancer. 2021;68(10):e29195.